RecruitingNAINTERVENTIONAL

Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders

This study is testing a new questionnaire called ESSME, designed by healthcare experts, to help understand people with schizophrenia or similar conditions in their everyday environment. The goal is to get a clearer picture of their daily challenges and concerns. By doing these assessments at home, the study hopes to make care more personal and relevant to each person's life, rather than just using standard clinic assessments. This could lead to better, more individualised care plans. Participants will have a few visits over about six months, including some at home, to complete these questionnaires.

At a glance

Status

Recruiting

Phase

Sponsor

Centre Hospitalier Henri Laborit

Enrolment target

Start

23 Feb 2022

Estimated completion

01 Feb 2026

Patients With Schizophrenia-like Disorders

What is this study about?

This research study is looking into a new way to understand and help people who have schizophrenia or similar conditions. When you're dealing with a condition like schizophrenia, everyday life can present unique challenges, and standard hospital or clinic questionnaires might not always capture the full picture of what really matters to you.

That's where this new tool, called the ESSME questionnaire, comes in. It's designed to be used in your own home environment. The idea is that by talking about your daily life and concerns where you live, healthcare teams can get a much better and more realistic understanding of your individual needs. This deeper understanding could then help them create care plans that are much more tailored to you and your personal goals.

The main aim is to make sure that the support you receive is as close as possible to what you experience day-to-day. By understanding your specific concerns in your own setting, the hope is to improve how care is given and make it more effective for you.

Key takeaways

Tests a new questionnaire (ESSME) for schizophrenia care.
Aims to understand daily life challenges through home visits.
Could lead to more personalised and relevant care.
Participation lasts about 6 months, with 4 planned visits.
Your current medication will not change during the study.
You can stop participating at any time.

Who may be eligible?

To be able to take part in this study, you need to be an adult, aged between 18 and 65 years old. You must have been diagnosed with either schizophrenia or a schizoaffective disorder by a doctor. Also, you need to be receiving care from a specialist centre called a CREATIV (Centre for Rehabilitation and Intersectoral Therapeutic Activities) and be signed up to a social security scheme.

There are also some reasons why you might not be able to join. For example, if you are pregnant or breastfeeding, or if you are not comfortable having study visits at your home, then this study wouldn't be suitable. Additionally, if you have certain other conditions like dementia, or if you can't understand French well enough to answer the questions, you wouldn't be able to participate. You also need to be happy to agree to take part.

Could this study suit you?

Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.

Are you between 18 and 65 years old?
Have you been diagnosed with schizophrenia or schizoaffective disorder?
Are you receiving care from a CREATIV centre?
Are you comfortable having study team members visit your home?
Do you understand and speak French well enough for questionnaires?
Are you not pregnant or breastfeeding?

Answer every question to see your result.

What does participation involve?

If you decide to take part in this study, your involvement will last for about six months, plus an extra 7 to 14 days at the beginning and end. During this time, you will have a total of four visits.

The first visit (V0) will be at the start, where you'll answer some standard questionnaires. About 7 to 14 days later, a member of the study team will visit you at your home (V1) to ask you questions from the new ESSME questionnaire.

Then, after six months (V2), you'll have another follow-up visit where you'll complete the same standard questionnaires as at your first visit. Finally, about 7 to 14 days after that six-month mark, you'll have one last home visit (V3) to complete the ESSME questionnaire again. You won't need to change any of your current medications for this study.

Potential risks and benefits

Participating in this study might offer a benefit by helping healthcare teams better understand your care needs through a more personal, home-based assessment, which could lead to more tailored support. While there aren't many direct risks, you might find some of the questions personal, and the home visits could be inconvenient. You are completely free to withdraw from the study at any time, for any reason, without it affecting your usual care.

Locations (1)

Centre Hospitalier Henri Laborit
Verified postcode
Poitiers, France· Recruiting

Common questions

What is a 'schizophrenia-like disorder'?

This refers to conditions like schizophrenia or schizoaffective disorder, which are mental health conditions that affect how a person thinks, feels, and behaves.

What is the ESSME questionnaire?

It's a new set of questions designed by healthcare professionals to understand your daily life and concerns in your own home environment. It's hoped to make care more personal.

Will my regular treatment change if I join?

No, your current treatment plan will not be changed or affected by your participation in this study.

Do I have to have people visit my home?

Yes, two of the four study visits will take place at your home to use the new questionnaire in your everyday environment.

How long will I be involved in the study?

Your involvement in the study will last for just over six months, during which you will have four visits.

How to find out more

Carole WANGERMEZ

carole.wangermez@ch-poitiers.fr +33 5 49 38 00 19 Official trial record

Always speak to your GP or specialist before deciding to take part in a study.